Literature DB >> 2993947

Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain.

E E Vasar, L K Ryago.   

Abstract

The behavioral and biochemical effects of intracerebroventricular administration of cholecystokinin were investigated in experiments on male Wistar rats. Cholecystokinin induced specific dose-dependent changes in the behavior of the animals. At low doses the inhibiting influence on behavior predominated; at high doses stereo-typed behavior, shaking of the head and increased reactivity to pain stimuli were observed. Cholecystokinin appreciably inhibited the circulation of serotonin and dopamine in the brain structures in comparison with physiological saline solution. Administration of cholecystokinin against a background of phenamine and 5-hydroxy-tryptophan briefly entirely inhibited the behavioral effects induced by these substances. On the basis of the data obtained it can be assumed that cholecystokinin is an endogenous modulator of the activity of the monoaminergic systems of the brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993947     DOI: 10.1007/bf01182992

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  12 in total

1.  Serotonin agonist actions of p-chlorophenylalanine.

Authors:  R S Sloviter; E G Drust; J D Connor
Journal:  Neuropharmacology       Date:  1978-12       Impact factor: 5.250

2.  Cholecystokinin receptors in the brain: characterization and distribution.

Authors:  A Saito; H Sankaran; I D Goldfine; J A Williams
Journal:  Science       Date:  1980-06-06       Impact factor: 47.728

3.  Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8).

Authors:  G Zetler
Journal:  Neuropharmacology       Date:  1980-05       Impact factor: 5.250

4.  Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain.

Authors:  G Curzon; A R Green
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

5.  Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain.

Authors:  R B Innis; F M Corrêa; G R Uhl; B Schneider; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection.

Authors:  K Fuxe; K Andersson; V Locatelli; L F Agnati; T Hökfelt; L Skirboll; V Mutt
Journal:  Eur J Pharmacol       Date:  1980-10-17       Impact factor: 4.432

7.  Immunochemical evidence of cholecystokinin-like peptides in brain.

Authors:  G J Dockray
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

8.  Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain.

Authors:  G J Dockray; R A Gregory; J B Hutchison; J I Harris; M J Runswick
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

9.  Cholecystokinins in rat cerebral cortex: identification, purification and characterization by immunochemical methods.

Authors:  G J Dockray
Journal:  Brain Res       Date:  1980-04-21       Impact factor: 3.252

10.  Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.

Authors:  G L Kovács; G Szabó; B Penke; G Telegdy
Journal:  Eur J Pharmacol       Date:  1981-01-29       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.